-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Maintains Market Outperform on AtriCure, Raises Price Target to $68

Benzinga·10/21/2026 13:08:14
Diffusion vocale
Citizens analyst Daniel Stauder maintains AtriCure (NASDAQ:ATRC) with a Market Outperform and raises the price target from $52 to $68.